| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of Mouwasat Medical Services is pleased to announce the results of the AGM (First Meeting) |
| City and Location of the General Assembly's Meeting | Through modern technology from the company's headquarters - Dammam |
| Date of the General Assembly's Meeting | 2026-05-04 Corresponding to 1447-11-17 |
| Time of the General Assembly’s Meeting | 18:30 |
| Percentage of Attending Shareholders | 47.33 % |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | The meeting was attended by the following board members: 1- Mr. Mohammad Sultan Alsubaie. 2- Mr. Nassir Sultan Alsubaei. 3- Mr. Khalid Suliman Alsaleem. 4- Dr. Sami Abdulkarim AlAbdulkarim. 5- Mr. Fahad Ayed Alaslami. 6- Dr. Mohammed Hamad Alkathiri. 7- Dr. Abdullah Saghaier Alhussaini. 8- Mr. Ibrahim Hamad Ababtain. |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | The meeting was attended by the following board members: 1- Mr. Nassir Sultan Alsubaei (Chairman of Executive Committee) 2- Dr. Mohammed Ibrahim Atwaijri (Chairman of Audit Committee) 3- Dr. Mohammed Hamad Alkathiri (Chairman of Nomination and Remunerations Committee) |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | 1- The Board of Directors’ report for the fiscal year ended December 31,2025. was reviewed and discussed. 2- Approval of the company’s external auditor's report for the fiscal year ending on 31/12/2025. 3- The financial statements for the fiscal year ended December 31,2025. was reviewed and discussed 4- Approval of appointing KPMG Professional Services the Auditor for the Company from among nominees based on the Audit Committee’s recommendation. The appointed auditor shall examine, review, and audit the (second and third) quarter and annual financial statements, of the fiscal year 2026, and the first quarter of fiscal year 2027, with the fees of SR 1,190,000 VAT excluded. 5- Approval of the Board’s recommendation to distribute cash dividends amounting to SR 225 million to the shareholders for the second half of the fiscal year 2025 at SR 1.125 per share representing 11.25% of the nominal value of the share. Provided that the entitlement is for shareholders holding the shares by the end of the trading day of Assembly date, and who are registered in the Company's Shareholders Registry held with the Security Depository Center Company (Edaa) at the end of the second trading day following the entitlement date, The disbursement of dividends will begin by transferring them to accounts associated with the portfolios of eligible shareholders as of Thursday 14/05/2026 through the Paying agent - Rajhi Bank, and any shareholder in the event of a failure of deposit in his account can contact the Paying agent – Rajhi Bank or communicate with the Company via email: shares@mouwasat.com. 6- Approval of the business and contracts that will be concluded for the fiscal year ending on 31/12/2026 between the Company and Mouwasat International Co. Limited, in which the Board members Mr. Mohammad Sultan Alsubaie (Non-Executive Member) and Mr. Nassir Sultan Alsubaei (Executive Member) have a direct interest, and the Board member Mr. Khalid Suliman Alsaleem (Executive Member) has an indirect interest, and the nature of transaction is a procurement contracts and other services according to the Company's procurement system without preferential terms with an estimated value of SR 3,000,000, noting that the value of transactions for the fiscal year ended on 31/12/2025 amounted to SR 2,896,408. 7- Approval of the business and contracts that will be concluded for the fiscal year ending on 31/12/2026 between the Company and Mouwasat International Co. Limited, in which the Board members Mr. Mohammad Sultan Alsubaie (Non-Executive Member) and Mr. Nassir Sultan Alsubaei (Executive Member) have a direct interest, and the Board member Mr. Khalid Suliman Alsaleem (Executive Member) has an indirect interest, and the nature of transaction is for medical and pharmaceutical supplies in accordance with the Company's procurement system without preferential terms with an estimated value of SR 20,000,000, noting that the value of transactions for the fiscal year ended on 31/12/2025 amounted to SR 17,388,744. 8- Approval of the business and contracts for the financial year ending on 31/12/2025 between the Company and Mouwasat International Co. Limited, in which the Board members Mr. Mohammad Sultan Alsubaie (Non-Executive Member) and Mr. Nassir Sultan Alsubaei (Executive Member) have a direct interest, and the Board member Mr. Khalid Suliman Alsaleem (Executive Member) has an indirect interest with value of SR 6,616,653, and the nature of transaction is for tickets and tourism and travel services according to the Company's system without preferential terms, noting that the contract ended on 31 May 2025. 9- Approval of the business and contracts that will be concluded for the fiscal year ending on 31/12/2026 between the Company and Advision for trading Est., in which the Board member Mr. Khalid Suliman Alsaleem (Executive Member) has a direct interest, and the nature of transactions are of advertising and marketing related in accordance with the Company's procurement system without preferential terms with an estimated value of SR 30,000,000 , noting that the value of transactions for the fiscal year ended on 31/12/2025 amounted to SR 27,533,945. 10- Approval of the authorization of the Board of Directors to distribute interim dividends to the Company’s shareholders on a semi-annual or quarterly basis for the fiscal year 2026. 11- Approval of the release Board members from liability for the period ended 31st of December 2025. |